Clinical Impact of Genetic Studies in Lethal Inherited Cardiac Arrhythmias
View Full Paper
Ask AI
Bookmark
Share
Key result
Molecular genetic studies have linked inherited cardiac arrhythmias to ion channel mutations, enabling genotype-specific risk stratification and therapy for Long QT and Brugada syndromes.
Population
Patients with lethal inherited cardiac arrhythmias, specifically congenital long QT syndrome and Brugada…
Design
Review
Authors
Discussion
Loading...
Member takes
Overview
May support genotype-specific management in Long QT and Brugada; leaves open prospective validation for broader adoption.
Structured PICO
P
Population
Patients with lethal inherited cardiac arrhythmias, specifically congenital long QT syndrome (LQTS) and Brugada syndrome (BrS).
I
Intervention
Molecular genetic studies and genotype-specific therapy
Molecular genetic testing in inherited arrhythmias like LQTS allows for genotype-specific risk stratification and targeted therapies, improving clinical management.
Limitations
- Only one-third of Brugada syndrome patients can currently be genotyped.
- Genetic studies of inherited arrhythmias other than congenital LQTS are still largely experimental.
Cite This Study
Wataru Shimizu (2008) conducted a review in Inherited cardiac arrhythmias (Long QT syndrome and Brugada syndrome). Genetic testing and genotype-specific therapy was evaluated. Molecular genetic studies have linked inherited cardiac arrhythmias to ion channel mutations, enabling genotype-specific risk stratification and therapy for Long QT and Brugada syndromes.
View Full Paper
Ask AI
Bookmark
Share